sábado, 7 de noviembre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 23, 2026

The Best Artificial Intelligence (AI) Growth Stocks on the Nasdaq That Wall Street Loves Right Now

View original at nasdaq.com
The Best Artificial Intelligence (AI) Growth Stocks on the Nasdaq That Wall Street Loves Right Now Key Points Wall Street analysts love these two artificial intelligence (AI) stocks…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Applied Digital is targeting $1 billion in net operating income (NOI) over the next five years

    60% confidence

  • Interest is high among hyperscalers for all of these new facilities

    60% confidence

  • If you invested $1,000 in Netflix on December 17, 2004, you'd have $502,837

    60% confidence

  • Roughly 93% of the 70 analysts who cover Nvidia say it is a buy with a median price target of $267.50, suggesting about 33% upside

    60% confidence

  • Stock Advisor's total average return is 977% compared to 200% for the S&P 500

    60% confidence

  • If you invested $1,000 in Nvidia on April 15, 2005, you'd have $1,241,433

    60% confidence

  • 100% of the 13 analysts that cover Applied Digital rate it a buy, with a median price target of $43 per share, suggesting 32% upside

    60% confidence

  • Some $4 trillion is projected to be spent on data centers in 2030 worldwide, up from $1 trillion in 2025

    60% confidence

Data points we hold from this source

S&P 500 · return200 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com
The Best Artificial Intelligence (AI) Growth Stocks on the Nasdaq That Wall Street Loves Right Now — Source | Via News | es.VIA.NEWS